Search results
Does VistaGen Therapeutics, Inc. (VTGN) Have the Potential to Rally 160% as Wall Street Analysts...
Zacks via Yahoo Finance· 2 months agoThe mean of analysts' price targets for VistaGen Therapeutics, Inc. (VTGN) points to a 160% upside...
Retail investors are Vistagen Therapeutics, Inc.'s (NASDAQ:VTGN) biggest owners and were rewarded...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significant control over Vistagen Therapeutics by retail investors implies that the...
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoVistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript February 13, 2024...
VistaGen Therapeutics, Inc. (VTGN) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoVistaGen Therapeutics, Inc. (VTGN) delivered earnings and revenue surprises of 0% and 388.07%,...
What Makes VistaGen Therapeutics, Inc. (VTGN) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoVistaGen Therapeutics, Inc. (VTGN) might move higher on growing optimism about its earnings...
Vistagen Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 2 months agoVistagen Therapeutics (NASDAQ:VTGN) Third Quarter 2024 Results Key Financial Results Net loss:...
Insiders who bought stock earlier this year lose -US$12k as VistaGen Therapeutics, Inc....
Simply Wall St. via Yahoo Finance· 2 years agoThe recent price decline of 15% in VistaGen Therapeutics, Inc.'s (NASDAQ:VTGN) stock may have...
Shareholders Will Likely Find VistaGen Therapeutics, Inc.'s (NASDAQ:VTGN) CEO Compensation...
Simply Wall St. via Yahoo Finance· 2 years agoThe performance at VistaGen Therapeutics, Inc. (NASDAQ:VTGN) has been rather lacklustre of late and...
Independent Biostatisticians Recommend Vistagen Continue Late-Stage Anxiety Trial
Benzinga via Yahoo Finance· 2 years agoVistagen Therapeutics Inc (NASDAQ: VTGN) completed an interim analysis of PALISADE-2, its second...
Vistagen Strengthens Its Neurology Focused Pipeline With Pherin Pharma Acquisition
Benzinga via Yahoo Finance· 1 year agoVistagen Therapeutics Inc (NASDAQ: VTGN) has agreed to acquire Pherin Pharmaceuticals Inc in an...